1 otocols could be enhanced by the presence of cyclohexylamine.

2 n of 1 with 254 nm light in cyclohexane gave cyclohexylamine 11, diamine 3c, and azobenzene 12 as the

3 ture of the major adduct between [Pt(ammine)(cyclohexylamine)]2+ and a DNA dodecamer, using the same

4                            Since [Pt(ammine)(cyclohexylamine)]2+ contains two different ligands, it c

5                 Its active form, [Pt(ammine)(cyclohexylamine)]2+, binds to DNA similarly to cisplatin

6 ,2R-diaminocyclohexane)](2+), cis-[Pt(NH(3))(cyclohexylamine)](2+), [Pt(ethylenediamine)](2+), cis-[P

7  the cellular processing of cis-[Pt(NH(3))- (cyclohexylamine)](2+), but not [Pt((1R,2R)-diaminocycloh

8                                         When cyclohexylamine, a spermidine synthase (SPDS) inhibitor,

9                                              Cyclohexylamine and 1,4-butanediamine (putrescine) are u

10   Protected alpha-guanidino acids coupled to cyclohexylamine and trans-1,4-diaminocyclohexane in good

11 s such as ethylenediamine, 4,4'-methylenebis(cyclohexylamine), and diethyltoluenediamine.

12 piperidine 4, we developed a novel series of cyclohexylamine- and piperidine-based benzenesulfonamide

13  Co(2)(CO)(8), in DME and in the presence of cyclohexylamine, are sufficient for the cyclocarbonylati

14 tiodeprotonation or deuteriodeprotonation in cyclohexylamine catalyzed by cesium cyclohexylamide.

15 diaminocyclohexane)Cl(2)] and cis-[Pt(NH(3))(cyclohexylamine)Cl(2)] were also examined.

16                         cis-trans-cis-Ammine(cyclohexylamine)diacetatodichloroplatinum(IV) is an oral

17 re improved resolution was the separation of cyclohexylamine (K(0) = 1.83) and 2-hexanone (K(0) = 1.8

18 ain 1,2-intrastrand cross-links in which the cyclohexylamine ligand is directed toward the 3'-end of

19  oxaliplatin, and (Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216), are repaired in vi